India To Start Receiving Sputnik V Vaccine Shots This Quarter, Production In India To Start From July
Russian Sputnik V Covid-19 vaccine (Pic Via Sputnik V website)
India is set to receive Russian Vaccine Sputnik V stocks in this quarter, between April and Jun, which was granted emergency use authorisation (EUA) earlier this week on Monday, 12 April reports
Times of India.
After Covishield and Covaxin, Sputnik V became the third Covid-19 vaccine to be used in the country.
As part of its contract with the Russian Direct Investment Fund (RDIF), Hyderabad-based Dr Reddyâs Laboratories (DRL) is expected to receive around 250 million doses of Sputnik V.
Hyderabad-based Dr Reddy’s Laboratories (DRL), the Indian partner for Russia’s Sputnik V, will use the government’s vaccination cold chain infrastructure, along with its own cold chain capabilities, for last-mile distribution of the vaccine in India.
Further, 60-70 per cent of Sputnik V’s global production is set to take place in India, said DRL.
Sputnik V, a vaccine with 91.6 per cent efficacy the highest among Covid vaccines available in India requires a temperature range of -18 degrees C to -22 degrees C to remain stable.
Deepak Sapra, CEO (API and Pharmaceutical Services), DRL, said they have already tested the cold chain infrastructure in India through simulations. “We have tested the cold chain in simulation scenarios from Hyderabad to as far as Manipur in the north-east, Ladakh in the north, and Tamil Nadu in south,” Sapra told reporters on Wednesday.
India’s drug regulatory expert panel on Monday approved restricted emergency use of Russia’s Sputnik V, paving the way for the entry of a third Covid-19 vaccine in India’s inoculation campaign currently open for people 45 years and older.
The subject expert committee (SEC) of the Central Drugs Standard Control Organisation approved an application for the emergency use authorisation for Sputnik V submitted by the Hyderabad-based Dr Reddy’s Laboratories, the PTI reported.
The Russia Direct Investment Fund (RDIF), the country’s sovereign wealth fund and the vaccine’s promoter worldwide, and Dr Reddy’s Laboratories, had last year said they would provide India 100 million doses of Sputnik V after its regulatory approval.
Sputnik V cleared for launch in India: Five things you onenewspage.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onenewspage.com Daily Mail and Mail on Sunday newspapers.